newsfeed-en
@SachsAssociates
8. Apr 2021 via Twitter
We are pleased to share the Revolutionising Hospital Care: New Technologies Panel, which took place at 2nd Annual European HealthTech CEO Forum #Sachs_EHTF.You can view it here: https://t.co/oGMaKhfFCU— Sachs Associates (@SachsAssociates) April 8, 2021
@SachsAssociates
8. Apr 2021 via Twitter
We are pleased to share the Introductory Speech by Jeffrey Cohen, Managing Director, Equity Research, Ladenburg Thalmann & Co. Inc., which took place at 2nd Annual European HealthTech CEO Forum #Sachs_EHTF.You can view it here: https://t.co/6Qr1XREhjB— Sachs Associates (@SachsAssociates) April 8, 2021
@SachsAssociates
8. Apr 2021 via Twitter
We are pleased to share the Digital Pharma & Drug Discovery Panel, which took place at 2nd Annual European HealthTech CEO Forum #Sachs_EHTF.You can view it here: https://t.co/2fZwXxumCt— Sachs Associates (@SachsAssociates) April 8, 2021
@SachsAssociates
8. Apr 2021 via Twitter
We are pleased to share the Digital Healthcare in the New Era of COVID-19 Panel, which took place at 2nd Annual European HealthTech CEO Forum #Sachs_EHTF.You can view it here: https://t.co/EAEJ2piAz0— Sachs Associates (@SachsAssociates) April 8, 2021
@eurocrowd
8. Apr 2021 via Twitter
The Crowd Angel, one of the leading Spanish #crowdfunding platforms for #startup investments and our dear member, recently introduced a new brand name, visual identity and an advanced platform, improving the investment experience. Meet @Dozeninvest 👏 https://t.co/2NCdgbtcXw— ECN (@eurocrowd) April 8, 2021
@SachsAssociates
8. Apr 2021 via Twitter
We are pleased to share the Greeting from State of Vaud, home of innovations speech, which took place at 2nd Annual European HealthTech CEO Forum #Sachs_EHTF.You can view it here: https://t.co/O8r5a4y5uR— Sachs Associates (@SachsAssociates) April 8, 2021
@SachsAssociates
7. Apr 2021 via Twitter
Richard Godfrey joined @BGenBio as CEO in 2008, he has extensive international drug development and commercial experience.e-Meet Richard at #Sachs_IOIFMore info @ https://t.co/tMBHnCypoC pic.twitter.com/ycWvovGTsX— Sachs Associates (@SachsAssociates) April 7, 2021
@SachsAssociates
7. Apr 2021 via Twitter
Marco Baptista joined the @MichaelJFoxOrg in 2012. As Vice President, Research Programs, Marco stays closely linked to the Parkinson's community in order to develop an aggressive and innovative agenda for accelerating research and drug development for Parkinson's disease. pic.twitter.com/5kuBBtNk5F— Sachs Associates (@SachsAssociate…
@SachsAssociates
7. Apr 2021 via Twitter
Dr. Buell(@jbuell01) brings over 20 years of biopharmaceutical industry experience. Her efforts in the rapid advancement of discovery candidates through development has resulted in @Agenus_Bio' record of advancing numerous I-O candidates to the clinic in the past four years. pic.twitter.com/yObbEUhqPw— Sachs Associates (@SachsAssociates)…
@SachsAssociates
6. Apr 2021 via Twitter
e-Meet Jennifer Buell, President & CEO of @Agenus_Bio at #Sachs_IOIFMore info @ https://t.co/tMBHnCypoC pic.twitter.com/Btj2i41pMV— Sachs Associates (@SachsAssociates) April 6, 2021